Bravo Pharma (Uk) Ltd
10493421
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
secretary · Since 23/11/2016
director · Since 23/11/2016
PHARMACIST
BRITISH · ENGLAND · Age 67
Also on 7 other boards
director · Since 04/09/2023
ACCOUNTANT
BRITISH · ENGLAND · Age 65
Also on 3 other boards
Persons with Significant Control
Ric Chemicals Ltd
Unit 1, Conqueror Court, Spilsby Road, Romford, RM3 8SB
Reg: 03091306 · Register Of Companies · Private Limited Company
Notified 23/11/2016
Mr Rakesh Pandey
Indian · United Arab Emirates · Age 48
Unit 1, Conqueror Court, Spilsby Road, Romford, RM3 8SB
Notified 19/05/2026
Former PSCs
Rakesh Pandey
Ceased 10/02/2023
Bravo Life Science Holding Pte. Ltd.
Ceased 04/06/2024
CompanyRankvs 1547+ SIC 47730 peers69
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/11/2024
Net Worth
£91k
Balance sheet strength
Cash
£3k
Cash in the bank
Net Current Assets
£91k
Working capital
Current Assets
£119k
Current Liabilities
£29k
Fixed Assets
£266
Debtors
£116k
Tax at Year End
Director Loans
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 4.14 | -£3k |
| 2023 | 3.83 | -£20k |
| 2022 | 1.27 | -£15k |
| 2021 | 1.47 | +£24k |
| 2020 | 6.98 | -£5k |
| 2019 | 1.21 | — |
| 2018 | 2.25 | — |
Derived from filed accounts. Not audited figures.